European flu season starts

28 January 2008

Europe's influenza season has opened, according to the European Influenza Surveillance Scheme and the Stockholm, Sweden-headquartered European Center for Disease Prevention and Control (ECDC). The two organizations confirm an upsurge in the number of laboratory-confirmed cases of the virus in several European Union countries.

To date, 13 European nations have reported significant influenza activity (Austria, Bulgaria, France, Hungary, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Slovenia, Spain, Switzerland and the UK). The increased activity is likely to spread and, if the virus behaves as in previous years, it will gradually move eastwards and northwards during the coming weeks, the ECDC said.

The agency estimates that seasonal influenza is responsible for between 40,000 and 220,000 excess deaths in Europe each year, depending upon the strain's virulence. This year's outbreak has been predominantly caused by a new strain of the A(H1) influenza virus, usually associated with mild epidemics.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight